In 2018, the global intravascular catheters market was worth USD 4.1 billion. This market is expected to grow at an impressive rate during the forecast period. The market is driven by increasing prevalence of neurological disorders and cardiovascular disorders as well as increased incidence of urinary tract infections.
Market growth is also due to rising hospitalization rates, high prevalence of chronic disease, increased number of ambulatory clinics and catheterization laboratories, and increasing use of catheters for minimally-invasive diagnostic and interventional procedures. The market is driven by the increasing prevalence of kidney disease, diseases associated with the urinary bladder, as well as other urological conditions. High incontinence rates are a result of a large global geriatric population. Market growth has been aided by a rising demand for high-quality, sterile catheters.
Intavascular catheters are an integral part of medical practice and are crucial in ICUs. Although their vital role in providing vascular access is important, patients can be exposed to various infectious complications such as catheter-related bloodstream infection (CRBSI), local sites infections, endocarditis and septic thrombophlebitis. The risk of mortality and morbidity associated with intravascular catheters has been a concern in the healthcare sector, which poses a problem for market growth. However, technological advances are expected to eradicate associated infections and increase demand for intravascular catheters over the forecast period.
The market is also faced with price competition, poor quality assurance and limited reimbursement in many countries. Different policies and regulations have been implemented by the governments of each country to provide medical coverage to millions of patients. Programs like the Child Health Insurance Program in the U.S. (CHIP), which offers low-cost coverage for children and, in certain cases, pregnant women, will help to increase the market's growth over the forecast period.
The market can be divided into two types based on product: short peripheral intravenous catheters, or PIVC (partial intravenous catheters), and integrated PIVC (full PIVC). With a market revenue of USD 2.85 billion in 2018, the short PVIC was the dominant product. It is expected to continue growing at the fastest rate over the forecast period. These PIVCs have a lower incidence of infections. Other factors, such as the increasing incidence of neurological, cardiovascular, oncological, gastroenterological, and other diseases, will drive demand for PIVCs in surgical intervention.
The intravascular catheters market can be divided into four categories based on their application: oncology (gastroenterology), gastroenterology, kidney disease, infectious diseases, etc. Other segments include surgical procedures that are performed due to trauma and other diseases like cardiovascular and urological disorders. This segment was the largest in 2018, with a market revenue of USD 1.75 billion. It is expected to continue growing at a steady pace over the forecast period.
Due to rising incidence of infectious diseases like HIV, tuberculosis and HPV, the infectious diseases segment will see the greatest growth. It is forecast to show a CAGR 15.0% during the forecast period. Avert, a U.K.-based HIV/AIDS charity, estimates that around 36.9 millions people are living with HIV in the world. According to the World Health Organization, approximately 10 million people worldwide were diagnosed with tuberculosis in 2017. This led to an estimated 1.6million deaths. The rising incidence of these diseases will likely increase hospital admissions and healthcare providers. This will drive demand for intravascular catheters.
The market can be divided into clinics, hospitals, Ambulatory Surgical Centers and homecare. The market was dominated by hospitals in 2018, with a revenue of USD 2.5 Billion. This segment is expected to continue growing at a steady pace over the forecast period. The high number of procedures performed to treat infectious diseases such as gastroenterology and cardiovascular disease is one reason.
ASCs are expected to grow at the fastest rate, with a CAGR of 13.5% during the forecast period. ASCs are independent healthcare providers that provide outpatient surgical care. ASCs have a lower cost of surgery than hospitals. ASCs are also safer and cleaner than hospitals, and therefore are more likely to get infections. These factors and the increasing incidence of neurological, gastroenterological, and cardiovascular diseases are expected to increase demand for intravascular catheters at ASCs.
The market can be divided by region into North America (MEA), Europe (Asia Pacific), Latin America (Latin America), and Middle East and Africa. The market was dominated by Asia Pacific in 2018, which had a market value of USD1.2 billion. This market is expected to continue growing at a profitable rate during the forecast period. Asia Pacific's high market share can be attributed to the growing prevalence of infectious and renal diseases, urological problems, and increasing inpatient and emergency department procedures. The market will be driven by a large population base in Asia Pacific during the forecast period.
The MEA market is expected to grow at a fastest pace, with a CAGR 13.3 % during the forecast period. Key factors driving this market include the increasing prevalence of heart disease and other anomalies in low and middle-income countries. The MEA market will be impacted by the following factors: continuous improvement in healthcare infrastructure, rising healthcare spending levels, and high unmet medical need.
This market is highly competitive. It includes a number of players involved in activities such research and product development as well as medical device manufacturing, raw materials supply and distribution and even post-sales service. Most players compete on technological variation. Cook Medical, Smiths Medical, Edwards Life Sciences Corporation, Medtronic Inc., Johnson & Johnson; McKesson Medical Surgical Inc. and Terumo Corporation are some of the major players in this market.
This report provides a forecast of revenue growth at the global, regional, or country level and also analyzes industry trends for each sub-segment from 2014 to 2025. Grand View Research has divided the global intravascular catheters market report by product, region, end use, and application.
Product Outlook (Revenue USD Million, 2014-2025)
Short PIVC
Integrated PIVC or Closed PIVC
App Outlook (Revenue USD Million, 2014-2025)
Oncology
Gastroenterology
Renal Disease
Infectious Diseases
Other
End-use Outlook (Revenue USD Million, 2014-2025)
Hospitals
Clinics
ASC
Homecare
Other
Regional Outlook (Revenue USD Million, 2014-2025)
North America
U.S.
Canada
Europe
Germany
U.K.
Spain
France
Italy
Russia
Asia Pacific
Japan
China
India
South Korea
Singapore
Australia
Latin America
Mexico
Brazil
Argentina
MEA
Saudi Arabia
South Africa
UAE
b. Global intravascular catheter market size was USD 4.1 billion in 2019, and is forecast to grow to USD 4.5 billion by 2020.
How is intravascular catheters market growth expected?b. Global intravascular catheters market will grow at a compound annual rate of 11.8% between 2019 and 2025, to reach USD 8.8 Billion by 2025.
Which segment had the largest intravascular catheters market shares?b. With a market share of 28.3%, the Asia Pacific was the dominant region in intravascular catheters. This can be attributed to increasing incidence of oncological diseases, infectious and renal disease, urological problems, and increased inpatient and emergency department procedures.
What are the major players in the intravascular catheters marketb. Among the key players in the intravascular catheters industry are Smiths Medical, Cook Medical, Edwards Life Sciences Corporation, Medtronic Inc., Johnson & Johnson; McKesson Medical Surgical Inc. and Terumo Corporation.
What are the driving factors for intravascular catheters?b. Market growth is being driven by the rising prevalence of cardiovascular diseases and end-stage renal disease.
Up Market Research published a new report titled “Intravascular Catheters Market research report which is segmented by End Use (Homecare, ASC, Clinics, Hospitals), by Product (Integrated/Closed PIVCs, Short), By Players/Companies among others, urinary tract infections, neurological disorders, increasing incidence of cardiovascular disorders”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Intravascular Catheters Market Research Report |
By End Use | Homecare, ASC, Clinics, Hospitals |
By Product | Integrated/Closed PIVCs, Short |
By Companies | among others, urinary tract infections, neurological disorders, increasing incidence of cardiovascular disorders |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 201 |
Number of Tables & Figures | 141 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by End Use (Homecare, ASC, Clinics, Hospitals), by Product (Integrated/Closed PIVCs, Short).
Intravascular Catheters Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Intravascular Catheters Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Intravascular Catheters Market Report:
Some other reports from this category!